189 related articles for article (PubMed ID: 36269797)
1. Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.
Elía A; Saldain L; Vanzulli SI; Helguero LA; Lamb CA; Fabris V; Pataccini G; Martínez-Vazquez P; Burruchaga J; Caillet-Bois I; Spengler E; Acosta Haab G; Liguori M; Castets A; Lovisi S; Abascal MF; Novaro V; Sánchez J; Muñoz J; Belizán JM; Abba MC; Gass H; Rojas P; Lanari C
Clin Cancer Res; 2023 Mar; 29(5):866-877. PubMed ID: 36269797
[TBL] [Abstract][Full Text] [Related]
2. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
[TBL] [Abstract][Full Text] [Related]
3. Steroid profile in patients with breast cancer and in mice treated with mifepristone.
Elía A; Saldain L; Lovisi S; Martínez Vazquez P; Burruchaga J; Lamb CA; Lüthy IA; Diez F; Homer NZM; Andrew R; Rojas P; Lanari C
Endocr Relat Cancer; 2024 Feb; 31(2):. PubMed ID: 37962553
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
[TBL] [Abstract][Full Text] [Related]
5. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
[TBL] [Abstract][Full Text] [Related]
6. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.
Sequeira G; Vanzulli SI; Rojas P; Lamb C; Colombo L; May M; Molinolo A; Lanari C
Oncotarget; 2014 May; 5(10):3246-60. PubMed ID: 24912774
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Progesterone Receptor in Breast Cancer: Mind the Short Form!
Ronchi C; Brisken C
Clin Cancer Res; 2023 Mar; 29(5):833-834. PubMed ID: 36547665
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
Abascal MF; Elia A; Alvarez M; Pataccini G; Sequeira G; Riggio M; Figueroa V; Lamb CA; Rojas PA; Spengler E; Martínez-Vazquez P; Burruchaga J; Liguori M; Sahores A; Wargon V; Molinolo A; Hewitt S; Lombes M; Sartorius C; Vanzulli SI; Giulianelli S; Lanari C
Int J Cancer; 2022 May; 150(9):1481-1496. PubMed ID: 34935137
[TBL] [Abstract][Full Text] [Related]
10. p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
Khan JA; Amazit L; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Endocrinol; 2011 Oct; 25(10):1710-24. PubMed ID: 21816898
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.
Mote PA; Gompel A; Howe C; Hilton HN; Sestak I; Cuzick J; Dowsett M; Hugol D; Forgez P; Byth K; Graham JD; Clarke CL
Breast Cancer Res Treat; 2015 Jun; 151(2):309-18. PubMed ID: 25917868
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
Wang H; Lee EW; Zhou L; Leung PC; Ross DD; Unadkat JD; Mao Q
Mol Pharmacol; 2008 Mar; 73(3):845-54. PubMed ID: 18042733
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.
Pathiraja TN; Shetty PB; Jelinek J; He R; Hartmaier R; Margossian AL; Hilsenbeck SG; Issa JP; Oesterreich S
Clin Cancer Res; 2011 Jun; 17(12):4177-86. PubMed ID: 21459801
[TBL] [Abstract][Full Text] [Related]
14. Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models.
Rosati R; Oppat K; Huang Y; Kim S; Ratnam M
BMC Cancer; 2020 Jun; 20(1):512. PubMed ID: 32493230
[TBL] [Abstract][Full Text] [Related]
15. Antiprogestins for breast cancer treatment: We are almost ready.
Elia A; Pataccini G; Saldain L; Ambrosio L; Lanari C; Rojas P
J Steroid Biochem Mol Biol; 2024 Jul; 241():106515. PubMed ID: 38554981
[TBL] [Abstract][Full Text] [Related]
16. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.
Mote PA; Bartow S; Tran N; Clarke CL
Breast Cancer Res Treat; 2002 Mar; 72(2):163-72. PubMed ID: 12038707
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hepatic progesterone and estrogen receptors in the female turtle, Chrysemys picta: relationship to vitellogenesis.
Custodia-Lora N; Novillo A; Callard IP
Gen Comp Endocrinol; 2004 Apr; 136(2):232-40. PubMed ID: 15028527
[TBL] [Abstract][Full Text] [Related]
18. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
Wargon V; Fernandez SV; Goin M; Giulianelli S; Russo J; Lanari C
Breast Cancer Res Treat; 2011 Apr; 126(2):319-32. PubMed ID: 20440553
[TBL] [Abstract][Full Text] [Related]
20. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.
Graham JD; Yager ML; Hill HD; Byth K; O'Neill GM; Clarke CL
Mol Endocrinol; 2005 Nov; 19(11):2713-35. PubMed ID: 15976005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
